ATC Group: A05AA01 Chenodeoxycholic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A05AA01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Bile and liver therapy
3
Bile therapy
4
Bile acid preparations
5
A05AA01
Chenodeoxycholic acid

Active ingredients in A05AA01

Active Ingredient
Description

Exogenous chenodeoxycholic acid is used as replacement therapy to restore the feedback inhibition lost due to the deficiency/absence of endogenous chenodeoxycholic acid. In CTX, deficiency of chenodeoxycholic acid causes a lack of feedback of cholesterol 7 alpha hydroxylase (CYP7A1) and HMG CoA reductase, causing increased production of atypical bile acids, bile alcohols and cholestanol that lead to the pathological consequences of the condition.

Medicines in this ATC group

Hong Kong (HK)

Turkey (TR)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.